Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sherman

Showing results (891-900 of 935) with videos related to

Pageof 94
Sort By:
Orthopaedic Journal of Sports Medicine|September 15, 2025
Pediatric Meniscotibial Ligament Complex Anatomy and BiomechanicsWillemijn H van Deursen, Thomas M Johnstone, Annelisse Cuellar-Montes, et al.
Cancer|May 23, 2018
Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristicsSerban Negoita, Eric J Feuer, Angela Mariotto, et al.
American Journal on Intellectual and Developmental Disabilities|November 14, 2018
Associations Between Medical History, Cognition, and Behavior in Youth With Down Syndrome: A Report From the Down Syndrome Cognition ProjectTracie C Rosser, Jamie O Edgin, George T Capone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC studyD Schadendorf, M M Amonkar, M Milhem, et al.
Cancer|August 24, 2005
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrenceRichard A Larson, Eric L Sievers, Edward A Stadtmauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2022
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III TrialSebastian Bauer, Robin L Jones, Jean-Yves Blay, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Genome-wide association studies of Down syndrome associated congenital heart defectsElizabeth R Feldman, Yunqi Li, David J Cutler, et al.
American Journal of Human Genetics|March 21, 2000
Survey of the fragile X syndrome CGG repeat and the short-tandem-repeat and single-nucleotide-polymorphism haplotypes in an African American populationD C Crawford, C E Schwartz, K L Meadows, et al.
Cancer|April 6, 2019
A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinomaMartin H Voss, Rupal S Bhatt, Nicholas J Vogelzang, et al.
American Journal of Human Genetics|January 17, 2003
Expansion of the fragile X CGG repeat in females with premutation or intermediate allelesSarah L Nolin, W Ted Brown, Anne Glicksman, et al.
Pageof 94

Showing results (891-900 of 935) with videos related to

Sort By:
Pageof 94
Orthopaedic Journal of Sports Medicine|September 15, 2025
Pediatric Meniscotibial Ligament Complex Anatomy and BiomechanicsWillemijn H van Deursen, Thomas M Johnstone, Annelisse Cuellar-Montes, et al.
Cancer|May 23, 2018
Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristicsSerban Negoita, Eric J Feuer, Angela Mariotto, et al.
American Journal on Intellectual and Developmental Disabilities|November 14, 2018
Associations Between Medical History, Cognition, and Behavior in Youth With Down Syndrome: A Report From the Down Syndrome Cognition ProjectTracie C Rosser, Jamie O Edgin, George T Capone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC studyD Schadendorf, M M Amonkar, M Milhem, et al.
Cancer|August 24, 2005
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrenceRichard A Larson, Eric L Sievers, Edward A Stadtmauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2022
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III TrialSebastian Bauer, Robin L Jones, Jean-Yves Blay, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Genome-wide association studies of Down syndrome associated congenital heart defectsElizabeth R Feldman, Yunqi Li, David J Cutler, et al.
American Journal of Human Genetics|March 21, 2000
Survey of the fragile X syndrome CGG repeat and the short-tandem-repeat and single-nucleotide-polymorphism haplotypes in an African American populationD C Crawford, C E Schwartz, K L Meadows, et al.
Cancer|April 6, 2019
A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinomaMartin H Voss, Rupal S Bhatt, Nicholas J Vogelzang, et al.
American Journal of Human Genetics|January 17, 2003
Expansion of the fragile X CGG repeat in females with premutation or intermediate allelesSarah L Nolin, W Ted Brown, Anne Glicksman, et al.
Pageof 94